InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,427.13
(
-2.31%
)
US TECH 100
18,601.20
(
-3.24%
)
Dow Jones
39,853.87
(
-1.25%
)
Brent Oil
80.26
(
-0.59%
)
Bitcoin
64,080.30
(
-1.98%
)
Post# of 1291
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bbking2003

Send PM Follow Ignore
Followers 21
Posts 1234
Boards Moderated 0
Alias Born 12/10/2010

bbking2003

Re: bbking2003 post# 612

Friday, 03/01/2013 10:42:23 AM

Friday, March 01, 2013 10:42:23 AM

Post# of 1291
Based upon conservative assumptions for the size of the refractory gout population (50-60K patients), penetration (12% in 2015), and duration of therapy (3 or 12 months depending on patient’s response), they estimate U.S. sales of $300MM.
8.0 million people in the US with gout and the market is growing at 3% to 5% per year.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up